Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

Detection of Erythropoiesis Stimulating Agents in urine samples using a capillary Western system.

Desharnais P, Naud JF, Ayotte C.

Drug Test Anal. 2018 Oct 26. doi: 10.1002/dta.2528. [Epub ahead of print]

PMID:
30365250
2.

Disaster preparedness in French paediatric hospitals 2 years after terrorist attacks of 2015.

Mortamet G, Lode N, Roumeliotis N, Baudin F, Javouhey E, Dubos F, Naud J; Groupe Francophone de Réanimation et Urgences Pédiatriques (GFRUP).

Arch Dis Child. 2018 Jun 2. pii: archdischild-2017-314658. doi: 10.1136/archdischild-2017-314658. [Epub ahead of print]

PMID:
29860227
3.

Drainage of Cerebrospinal Fluid and Blood Pressure Augmentation as Rescue Therapies for Ischemic Myelitis After Bronchial Embolization: A Case Report.

Lépine PA, Naud JF, Boisvert P.

A A Pract. 2018 Jun 1;10(11):288-289. doi: 10.1213/XAA.0000000000000687.

PMID:
29851658
4.

Immunomagnetic beads-based isolation of erythropoietins from urine and blood for sports anti-doping control.

Desharnais P, Naud JF, Ayotte C.

Drug Test Anal. 2017 Nov;9(11-12):1744-1752. doi: 10.1002/dta.2320. Epub 2017 Nov 13.

PMID:
28994210
5.

A case-control evaluation of fungiform papillae density in burning mouth syndrome.

Naud JM, Benca L, Drangsholt MT, LeResche L, Coldwell SE.

Laryngoscope. 2018 Apr;128(4):841-846. doi: 10.1002/lary.26828. Epub 2017 Aug 22.

PMID:
28833164
6.

[Emergency medical aid in a paediatrics context].

Branchard D, Tentillier É, Gillet S, Naud J.

Soins Pediatr Pueric. 2016 Sep-Oct;37(292):12-16. doi: 10.1016/j.spp.2016.07.002. French.

PMID:
27664303
7.

Changes in Urinary and Serum Levels of Novel Biomarkers after Administration of Gadolinium-based Contrast Agents.

Mawad H, Laurin LP, Naud JF, Leblond FA, Henley N, Vallée M, Pichette V, Leblanc M.

Biomark Insights. 2016 Jun 29;11:91-4. doi: 10.4137/BMI.S39199. eCollection 2016.

8.

Effects of Chronic Renal Failure on Brain Cytochrome P450 in Rats.

Naud J, Harding J, Lamarche C, Beauchemin S, Leblond FA, Pichette V.

Drug Metab Dispos. 2016 Aug;44(8):1174-9. doi: 10.1124/dmd.116.070052. Epub 2016 Jun 6.

9.

Ariadne's thread: a promising new multidisciplinary tool to foster clients' resilience throughout the rehabilitation process.

Royer N, Bourdages-Perreault L, Cornelier G, Coutya J, Naud JM, Chouinard J, Levasseur M.

Disabil Rehabil. 2016 Jul;38(15):1454-62. doi: 10.3109/09638288.2015.1105310. Epub 2015 Dec 22.

PMID:
26694023
10.

[Apparent life-threatening events and sudden unexpected death in infancy: Two different entities].

Naud J.

Arch Pediatr. 2015 Sep;22(9):1000-4. doi: 10.1016/j.arcped.2015.05.021. Epub 2015 Jul 27. French.

PMID:
26228810
11.

[Drug pharmacokinetics in renal failure: What's new?].

Naud J, Dumayne C, Nolin TD, Leblond FA, Pichette V.

Nephrol Ther. 2015 Jun;11(3):144-51. doi: 10.1016/j.nephro.2014.12.006. Epub 2015 Apr 7. Review. French.

PMID:
25861715
12.

Effect of experimental kidney disease on the functional expression of hepatic reductases.

Alshogran OY, Naud J, Ocque AJ, Leblond FA, Pichette V, Nolin TD.

Drug Metab Dispos. 2015 Jan;43(1):100-6. doi: 10.1124/dmd.114.061150. Epub 2014 Oct 20.

13.

[Viral epidemiology and clinical severity during the peak of the influenza A(H1N1) variant epidemic in febrile respiratory diseases of children].

Feret V, Naud J, Harambat J, Malato L, Fleury H, Fayon M.

Arch Pediatr. 2014 Jul;21(7):709-15. doi: 10.1016/j.arcped.2014.04.017. Epub 2014 Jun 16. French.

PMID:
24947110
14.

Structure-based design of novel HCV NS5B thumb pocket 2 allosteric inhibitors with submicromolar gt1 replicon potency: discovery of a quinazolinone chemotype.

Beaulieu PL, Coulombe R, Duan J, Fazal G, Godbout C, Hucke O, Jakalian A, Joly MA, Lepage O, Llinàs-Brunet M, Naud J, Poirier M, Rioux N, Thavonekham B, Kukolj G, Stammers TA.

Bioorg Med Chem Lett. 2013 Jul 15;23(14):4132-40. doi: 10.1016/j.bmcl.2013.05.037. Epub 2013 May 23.

PMID:
23768906
15.

Synthesis and optimization of a novel series of HCV NS3 protease inhibitors: 4-arylproline analogs.

Bilodeau F, Bailey MD, Bhardwaj PK, Bordeleau J, Forgione P, Garneau M, Ghiro E, Gorys V, Halmos T, Jolicoeur ES, Leblanc M, Lemke CT, Naud J, O'Meara J, White PW, Llinàs-Brunet M.

Bioorg Med Chem Lett. 2013 Jul 15;23(14):4267-71. doi: 10.1016/j.bmcl.2013.03.043. Epub 2013 Mar 19.

PMID:
23735741
16.

Desialylation improves the detection of recombinant erythropoietins in urine samples analyzed by SDS-PAGE.

Desharnais P, Naud JF, Ayotte C.

Drug Test Anal. 2013 Nov-Dec;5(11-12):870-6. doi: 10.1002/dta.1494. Epub 2013 May 29.

PMID:
23720238
17.

Paediatric community-acquired septic shock: results from the REPEM network study.

Van de Voorde P, Emerson B, Gomez B, Willems J, Yildizdas D, Iglowstein I, Kerkhof E, Mullen N, Pinto CR, Detaille T, Qureshi N, Naud J, De Dooy J, Van Lancker R, Dupont A, Boelsma N, Mor M, Walker D, Sabbe M, Hachimi-Idrissi S, Da Dalt L, Waisman H, Biarent D, Maconochie I, Moll H, Benito J.

Eur J Pediatr. 2013 May;172(5):667-74. doi: 10.1007/s00431-013-1930-x. Epub 2013 Jan 26.

18.

Influence of SLCO1B3 genetic variations on tacrolimus pharmacokinetics in renal transplant recipients.

Boivin AA, Cardinal H, Barama A, Naud J, Pichette V, Hébert MJ, Roger M.

Drug Metab Pharmacokinet. 2013;28(3):274-7. Epub 2012 Nov 13.

19.

Nilotinib and imatinib inhibit cytarabine cellular uptake: implications for combination therapy.

Naud JS, Ghani K, de Campos-Lima PO, Caruso M.

Leuk Res. 2012 Oct;36(10):1311-4. doi: 10.1016/j.leukres.2012.06.012. Epub 2012 Jul 12.

PMID:
22796208
20.

New structural determinants for c-Myc specific heterodimerization with Max and development of a novel homodimeric c-Myc b-HLH-LZ.

Beaulieu ME, McDuff FO, Frappier V, Montagne M, Naud JF, Lavigne P.

J Mol Recognit. 2012 Jul;25(7):414-26. doi: 10.1002/jmr.2203.

PMID:
22733550
21.

Prey selectivity of the octocoral Carijoa riisei at Pernambuco, Brazil.

Gomes PB, Lira AK, Naud JP, Santos AM, Pérez CD.

An Acad Bras Cienc. 2012 Mar;84(1):157-64.

22.

Current understanding of drug disposition in kidney disease.

Naud J, Nolin TD, Leblond FA, Pichette V.

J Clin Pharmacol. 2012 Jan;52(1 Suppl):10S-22S. doi: 10.1177/0091270011413588. Review.

PMID:
22232747
23.

Effects of chronic renal failure on brain drug transporters in rats.

Naud J, Laurin LP, Michaud J, Beauchemin S, Leblond FA, Pichette V.

Drug Metab Dispos. 2012 Jan;40(1):39-46. doi: 10.1124/dmd.111.041145. Epub 2011 Oct 3.

24.

Effects of chronic renal failure on kidney drug transporters and cytochrome P450 in rats.

Naud J, Michaud J, Beauchemin S, Hébert MJ, Roger M, Lefrancois S, Leblond FA, Pichette V.

Drug Metab Dispos. 2011 Aug;39(8):1363-9. doi: 10.1124/dmd.111.039115. Epub 2011 Apr 27.

25.

[Clinical features and outcome of 2009 H1N1 influenza in the pediatric setting. Multicenter prospective study in the ED].

Desmoulins C, Michard-Lenoir AP, Naud J, Claudet I, Nouyrigat V, Chéron G.

Arch Pediatr. 2011 May;18(5):505-11. doi: 10.1016/j.arcped.2011.02.005. Epub 2011 Apr 1. French.

PMID:
21458977
26.

Discovery of a potent and selective noncovalent linear inhibitor of the hepatitis C virus NS3 protease (BI 201335).

Llinàs-Brunet M, Bailey MD, Goudreau N, Bhardwaj PK, Bordeleau J, Bös M, Bousquet Y, Cordingley MG, Duan J, Forgione P, Garneau M, Ghiro E, Gorys V, Goulet S, Halmos T, Kawai SH, Naud J, Poupart MA, White PW.

J Med Chem. 2010 Sep 9;53(17):6466-76. doi: 10.1021/jm100690x.

PMID:
20715823
27.

Reduced hepatic synthesis of calcidiol in uremia.

Michaud J, Naud J, Ouimet D, Demers C, Petit JL, Leblond FA, Bonnardeaux A, Gascon-Barré M, Pichette V.

J Am Soc Nephrol. 2010 Sep;21(9):1488-97. doi: 10.1681/ASN.2009080815. Epub 2010 Jul 1.

28.

The Arf tumor suppressor protein inhibits Miz1 to suppress cell adhesion and induce apoptosis.

Herkert B, Dwertmann A, Herold S, Abed M, Naud JF, Finkernagel F, Harms GS, Orian A, Wanzel M, Eilers M.

J Cell Biol. 2010 Mar 22;188(6):905-18. doi: 10.1083/jcb.200908103.

29.

Down-regulation of liver drug-metabolizing enzymes in a murine model of chronic renal failure.

Dani M, Boisvert C, Michaud J, Naud J, Lefrançois S, Leblond FA, Pichette V.

Drug Metab Dispos. 2010 Mar;38(3):357-60. doi: 10.1124/dmd.109.029991. Epub 2009 Dec 9.

30.

ESRD impairs nonrenal clearance of fexofenadine but not midazolam.

Nolin TD, Frye RF, Le P, Sadr H, Naud J, Leblond FA, Pichette V, Himmelfarb J.

J Am Soc Nephrol. 2009 Oct;20(10):2269-76. doi: 10.1681/ASN.2009010082. Epub 2009 Aug 20.

31.

[Medical training on mannequins: interests and limits].

Brissaud O, Villega F, Nolent P, Naud J.

Arch Pediatr. 2009 Jun;16(6):896-8. doi: 10.1016/S0929-693X(09)74195-8. French. No abstract available.

PMID:
19541213
32.

The Max homodimeric b-HLH-LZ significantly interferes with the specific heterodimerization between the c-Myc and Max b-HLH-LZ in absence of DNA: a quantitative analysis.

McDuff FO, Naud JF, Montagne M, Sauvé S, Lavigne P.

J Mol Recognit. 2009 Jul-Aug;22(4):261-9. doi: 10.1002/jmr.938.

PMID:
19189276
33.

The use of chemical double-mutant cycles in biomolecular recognition studies: application to HCV NS3 protease inhibitors.

Kawai SH, Bailey MD, Halmos T, Forgione P, Laplante SR, Llinàs-Brunet M, Naud J, Goudreau N.

ChemMedChem. 2008 Nov;3(11):1654-7. doi: 10.1002/cmdc.200800214. No abstract available.

PMID:
18942693
34.

Effect of hemodialysis on hepatic cytochrome P450 functional expression.

Michaud J, Nolin TD, Naud J, Dani M, Lafrance JP, Leblond FA, Himmelfarb J, Pichette V.

J Pharmacol Sci. 2008 Oct;108(2):157-63. Epub 2008 Oct 9.

35.

Permanent renal failure induced by pentastarch.

Jamal R, Ghannoum M, Naud JF, Turgeon PP, Leblanc M.

NDT Plus. 2008 Oct;1(5):322-5. doi: 10.1093/ndtplus/sfn075. Epub 2008 Jun 23.

36.

Potent triazolyl-proline-based inhibitors of HCV NS3 protease.

Naud J, Lemke C, Goudreau N, Beaulieu E, White PD, Llinàs-Brunet M, Forgione P.

Bioorg Med Chem Lett. 2008 Jun 1;18(11):3400-4. doi: 10.1016/j.bmcl.2008.04.012. Epub 2008 Apr 10.

PMID:
18448339
37.

Downregulation of hepatic acetylation of drugs in chronic renal failure.

Simard E, Naud J, Michaud J, Leblond FA, Bonnardeaux A, Guillemette C, Sim E, Pichette V.

J Am Soc Nephrol. 2008 Jul;19(7):1352-9. doi: 10.1681/ASN.2007090974. Epub 2008 Apr 16. No abstract available.

38.

Emerging evidence of the impact of kidney disease on drug metabolism and transport.

Nolin TD, Naud J, Leblond FA, Pichette V.

Clin Pharmacol Ther. 2008 Jun;83(6):898-903. doi: 10.1038/clpt.2008.59. Epub 2008 Apr 2. Review.

PMID:
18388866
39.

Biomarkers in Acute Kidney Injury.

Naud JF, Leblanc M.

Biomark Insights. 2008 Feb 26;3:115-125. No abstract available.

40.
41.

Effects of chronic renal failure on liver drug transporters.

Naud J, Michaud J, Leblond FA, Lefrancois S, Bonnardeaux A, Pichette V.

Drug Metab Dispos. 2008 Jan;36(1):124-8. Epub 2007 Oct 16.

42.
43.

PIM1 and MYC: a changing relationship?

Naud JF, Eilers M.

Nat Cell Biol. 2007 Aug;9(8):873-5. No abstract available.

PMID:
17671454
44.

[Quality of training and professional outcomes of medical students in pediatric residency programs: survey of graduating classes between 1990 and 2000, in the western interregion].

Anne C, Naud J, Bonnemains C, Hoppé A, Giniès JL.

Arch Pediatr. 2007 Oct;14(10):1259-63. Epub 2007 Jun 26. French.

PMID:
17596920
45.

Optimization and determination of the absolute configuration of a series of potent inhibitors of human papillomavirus type-11 E1-E2 protein-protein interaction: a combined medicinal chemistry, NMR and computational chemistry approach.

Goudreau N, Cameron DR, Déziel R, Haché B, Jakalian A, Malenfant E, Naud J, Ogilvie WW, O'meara J, White PW, Yoakim C.

Bioorg Med Chem. 2007 Apr 1;15(7):2690-700. Epub 2007 Jan 24.

PMID:
17306550
46.

Down-regulation of intestinal drug transporters in chronic renal failure in rats.

Naud J, Michaud J, Boisvert C, Desbiens K, Leblond FA, Mitchell A, Jones C, Bonnardeaux A, Pichette V.

J Pharmacol Exp Ther. 2007 Mar;320(3):978-85. Epub 2006 Nov 29.

47.

The mechanism of discrimination between cognate and non-specific DNA by dimeric b/HLH/LZ transcription factors.

Sauvé S, Naud JF, Lavigne P.

J Mol Biol. 2007 Jan 26;365(4):1163-75. Epub 2006 Oct 19.

PMID:
17109882
48.

Role of parathyroid hormone in the downregulation of liver cytochrome P450 in chronic renal failure.

Michaud J, Naud J, Chouinard J, Désy F, Leblond FA, Desbiens K, Bonnardeaux A, Pichette V.

J Am Soc Nephrol. 2006 Nov;17(11):3041-8. Epub 2006 Oct 4.

49.

Use of a fluorescent substrate for the selective quantification of rat CYP3A in the liver and the intestine.

Michaud J, Leblond FA, Naud J, Boisvert C, Desbiens K, Nicoll-Griffith DA, Pichette V.

J Pharmacol Toxicol Methods. 2007 Mar-Apr;55(2):209-13. Epub 2006 Aug 4.

PMID:
16979351
50.

Supplemental Content

Support Center